Vectra 3D, External antiparasitic for dogs , 3 pipettes, Ceva Sante

External antiparasitic for dogs between 1.5-4 kg Vectra 3D, 3 pipettes, Ceva Sante

Indications:
Fleas:
– treatment and prevention of flea infestation (Ctenocephalides felis and Ctenocephalides canis);
– the treatment prevents flea infestation for one month. It also prevents flea multiplication for two months after application by inhibiting egg hatching (ovicidal activity) and by inhibiting the emergence of adults from eggs laid by adult fleas (larvicidal activity);
– the veterinary medicinal product can be used as part of a treatment strategy for allergic dermatitis caused by fleas;
Ticks:
– the veterinary medicinal product has acaricidal efficacy and persistent repellent against tick infestation (Rhipicephalus sanguineus and ixodes ricinus for one month, and for Dermacentor reticulates up to three weeks);
– if ticks are present at the time of application, they may not die within the first 48 hours, but they may die within a week;
– for the removal of ticks it is recommended to use an appropriate device;
Sandflies, mosquitoes and stable flies:
– the treatment provides a persistent repellent action;
– prevents bites by sandflies (Phelbotomus perniciosus), mosquitoes (Culex pipiens, Aedes aegypti) and stable flies (Stomoxys calcitrans) for one month after application;
– the treatment also provides a persistent insecticidal activity for one month against mosquitoes (Aedes aegypti) and stable flies.

Method of administration:
Spot-on administration.
Care must be taken to apply the product to intact skin.
Dosage:
The minimum recommended dose is 6.4 mg dinotefuran/kg body weight, 0.6 mg pyriproxyfen/kg body weight and 46.6 mg permethrin/kg body weight, which is equivalent to 0.12 ml of veterinary medicinal product/kg body weight.

Treatment regimen:
The treatment may be repeated once a month if recommended by the veterinarian.

Contraindications:
Do not use in case of hypersensitivity to the active substance or to any of the excipients.
Do not administer to cats.
Due to their unique physiology and inability to metabolize permethrin, this veterinary medicinal product should not be administered to cats.
If applied to cats or ingested by a cat, this veterinary medicinal product may have harmful effects.

Adverse reactions:
Very rarely, erythema, pruritus or other signs of discomfort at the application site have been reported, which disappear spontaneously within less than 24 hours of administration of the product.
Gastrointestinal reactions such as vomiting or diarrhea have also been reported very rarely.

Target species:
Dogs.

Precautions:
All dogs in the household should be treated.
Cats should be treated with a medicinal product authorised for use in this species.
Fleas may infest the dog’s basket, bedding and resting areas such as carpets or interior decorations.
In the event of a massive flea infestation, at the beginning of control measures, these areas should be treated with an appropriate insecticide and then vacuumed regularly.
Do not administer to cats.
If the product has been accidentally ingested, it may cause convulsions in cats, which may be fatal.
In case of accidental exposure, wash the cat with shampoo or soap and seek immediate veterinary advice.
To prevent accidental exposure of cats to this veterinary medicinal product, keep cats separate from treated dogs until the application site is dry.
It is important that cats do not lick the application site of the veterinary medicinal product on dogs.
In case of such exposure, seek veterinary advice.
For external use only.
The safety of the veterinary medicinal product has not been established in puppies less than 7 weeks of age or weighing less than 1.5 kg.
Care should be taken to avoid contact of the veterinary medicinal product with the dog’s eyes.
After treatment, tick attachment cannot be excluded, therefore transmission of infectious diseases cannot be completely excluded if conditions are favourable.
The product remains effective when dogs are introduced into water (bathing, swimming).
Repeated weekly introduction into the water for one month and starting within 48 hours of treatment as well as shampooing 2 weeks after treatment do not affect the efficacy of the product.
However, in the case of frequent shampooing or bathing less than 48 hours after treatment, the duration of activity of the product may be reduced.
Treated dogs should not enter surface waters for 48 hours after treatment to avoid adverse effects on aquatic organisms.
Do not mix with any other veterinary medicinal product and do not apply together with another veterinary medicinal product at the same time and in the same place.

Pregnancy and lactation:
The safety of the veterinary medicinal product has not been established during pregnancy and lactation in bitches.
Use of the product in pregnant or lactating bitches, or in dogs used for breeding, should be based on the benefit/risk assessment by the veterinarian.
Laboratory studies with each component, dinotefuran, pyriproxyfen or permethrin in rats and rabbits did not produce any maternotoxic, teratogenic or fetotoxic effects.
Dinotefuran has been observed to cross the blood-milk barrier and is excreted in milk.
N-methylpyrrolidone, an excipient of the veterinary medicinal product, has been shown to have a teratogenic effect in laboratory animals.

Overdose:
Apart from erythema and cosmetic changes to the coat at the application site, no other adverse reactions were observed in 7-week-old puppies treated topically 7 times at 2-week intervals with doses up to 5 times the recommended dose.
After accidental ingestion of the maximum recommended dose, vomiting, salivation and diarrhea may occur.
However, these signs disappear without the need for any treatment.

Presentation:
3 pipettes